Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system

被引:48
作者
Hu, Fu-Qiang [1 ]
Zhang, Yu [1 ]
Du, Yong-Zhong [1 ]
Yuan, Hong [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China
关键词
nimodipine; lipid nanospheres; solvent diffusion method; monostearin; caprylic/capric triglycerides; drug entrapment efficiency;
D O I
10.1016/j.ijpharm.2007.07.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To overcome the disadvantages such as lower drug entrapment efficiency (EE) of lipid nanospheres prepared by conventional solvent diffusion method, a solvent diffusion method in drug saturated aqueous system was developed. Nimodipine was used as a model drug to incorporate into lipid nanospheres. The monostearin (MS) solid lipid nanoparticles (SLN) produced by conventional method under different production temperature only showed 24.40-30.21 wt% EE, and relatively higher EE was achieved when the production temperature was 0 degrees C. The EE could be enhanced by the incorporation of liquid lipid (caprylic/capric triglycerides, CT) into SLN and the employing of drug saturated dispersion medium. The nanostructured lipid carrier (NLC) with higher CT content indicated the highest EE as the drug saturated aqueous solution was used as dispersion medium. The differential scanning calorimetry (DSC) results demonstrated the present method could improve the drug encapsulation into lipid nanospheres. In vitro drug release experiments indicated the present preparation method could delay the drug release rate from lipid nanospheres, and the drug release rate could adjust by the CT content in lipid nanospheres. The highest drug loading (DL) was reached up to 4.22 wt% when 8 wt% drug was charged in the preparation of lipid nanospheres. (c) 2007 Published by Elsevier B.V.
引用
收藏
页码:146 / 152
页数:7
相关论文
共 20 条
[1]   Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin [J].
Cavalli, R ;
Gasco, MR ;
Chetoni, P ;
Burgalassi, S ;
Saettone, MF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 238 (1-2) :241-245
[2]   Interactions of amphiphilic calix[4]arene-based Solid Lipid Nanoparticles with bovine serum albumin [J].
Gualbert, J ;
Shahgaldian, P ;
Coleman, AW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 257 (1-2) :69-73
[3]   Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system [J].
Hu, FQ ;
Jiang, SP ;
Du, YZ ;
Yuan, H ;
Ye, YQ ;
Zeng, S .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2005, 45 (3-4) :167-173
[4]   Preparation and characterization of solid lipid nanoparticles containing peptide [J].
Hu, FQ ;
Hong, Y ;
Yuan, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 273 (1-2) :29-35
[5]   Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization [J].
Hu, FQ ;
Yuan, H ;
Zhang, HH ;
Fang, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :121-128
[6]   Preparation and characteristics of monostearin nanostructured lipid carriers [J].
Hu, Fu-Qiang ;
Jiang, Sai-Ping ;
Du, Yong-Zhong ;
Yuan, Hong ;
Ye, Yi-Qing ;
Zeng, Su .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 314 (01) :83-89
[7]  
Jenning V, 2001, J MICROENCAPSUL, V18, P149
[8]   Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids [J].
Jenning, V ;
Thünemann, AF ;
Gohla, SH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (02) :167-177
[9]   Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases [J].
Lu, B ;
Xiong, SB ;
Yang, H ;
Yin, XD ;
Chao, RB .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 (1-2) :86-95
[10]   Solid lipid nanoparticles -: Production, characterization and applications [J].
Mehnert, W ;
Mäder, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (2-3) :165-196